home / stock / sngx / sngx news

SNGX News and Press, Soligenix Inc. From 10/03/19

Stock Information
Company Name: Soligenix Inc.
Stock Symbol: SNGX
Market: NASDAQ
Website: soligenix.com
Menu
SNGX SNGX Quote SNGX Short SNGX News SNGX Articles SNGX Message Board
Get SNGX Alerts

News, Short Squeeze, Breakout and More Instantly...
SNGX - Soligenix to Present at the 20th Annual GCFF Investor Conference in Vancouver, British Columbia, Canada

PRINCETON, N.J. , Oct. 3, 2019 /PRNewswire/ -- Soligenix, Inc. (Nasdaq: SNGX) (Soligenix or the Company), a late-stage biopharmaceutical company focused on developing and commercializing products to treat rare diseases where there is an unmet medical need, announced today that its Chief S...
SNGX - Soligenix Appoints Daniel P. Ring as Vice President of Business Development and Strategic Planning

PRINCETON, N.J. , Sept. 16, 2019 /PRNewswire/ -- Soligenix, Inc. (Nasdaq: SNGX) (Soligenix or the Company), a late-stage biopharmaceutical company focused on developing and commercializing products to treat rare diseases where there is an unmet medical need, announced today that it has ap...

SNGX - Soligenix names Jonathan Guarino as CFO

Soligenix ( SNGX ) announced appointment of Jonathan Guarino, as its Senior Vice President and Chief Financial Officer. More news on: Soligenix, Inc., Healthcare stocks news, Read more ...

SNGX - Soligenix Appoints Jonathan Guarino as Chief Financial Officer

PRINCETON, N.J. , Sept. 11, 2019 /PRNewswire/ -- Soligenix, Inc. (Nasdaq: SNGX) (Soligenix or the Company), a late-stage biopharmaceutical company focused on developing and commercializing products to treat rare diseases where there is an unmet medical need, announced today that it h...
SNGX - Soligenix to Present at the RHK Capital 2019 Disruptive Growth Conference

PRINCETON, N.J. , Aug. 29, 2019 /PRNewswire/ -- Soligenix, Inc. (Nasdaq: SNGX) (Soligenix or the Company), a late-stage biopharmaceutical company focused on developing and commercializing products to treat rare diseases where there is an unmet medical need, announced today that its Presid...

SNGX - LCI, TGE among premarket gainers

DPW Holdings (NYSEMKT: DPW ) +51%  on eliminating $2M of debt. More news on: DPW Holdings, Inc., Lannett Company, Inc., Tallgrass Energy, LP, Stocks on the move, Read more ...

SNGX - Soligenix to boost enrolment in late-stage study of SGX942 in oral mucositis

Based on a preplanned interim analysis, the independent Data Monitoring Committee (DMC) has recommended that the Phase 3 DOM-INNATE study evaluating Soligenix's (NASDAQ: SNGX ) SGX942 (dusquetide) for the treatment of oral mucositis in head and neck cancer patients receiving ch...
SNGX - Soligenix Announces Positive Recommendation by Independent Data Monitoring Committee on its Phase 3 Clinical Trial of SGX942 for the Treatment of Oral Mucositis in Head and Neck Cancer

PRINCETON, N.J. , Aug. 28, 2019 /PRNewswire/ -- Soligenix, Inc. (Nasdaq: SNGX) (Soligenix or the Company), a late-stage biopharmaceutical company focused on developing and commercializing products to treat rare diseases where there is an unmet medical need, announced today it has rec...

SNGX - Soligenix Announces $150,000 NIH Small Business Innovation Research Award Supporting Evaluation of SGX942 in Pediatric Indications

PRINCETON, N.J. , Aug. 15, 2019 /PRNewswire/ -- Soligenix, Inc. (Nasdaq: SNGX) (Soligenix or the Company), a late-stage biopharmaceutical company focused on developing and commercializing products to treat rare diseases where there is an unmet medical need, announced today that the Nation...

SNGX - Soligenix EPS beats by $0.02, beats on revenue

Soligenix (NASDAQ: SNGX ): Q2 GAAP EPS of -$0.12 beats by $0.02 . More news on: Soligenix, Inc., Earnings news and commentary, Healthcare stocks news, , Read more ...

Previous 10 Next 10